Cost-effectiveness of exome sequencing: an Italian pilot study on undiagnosed patients
Recent advances in genomic sequencing and their implementation in clinical practice are widely recognized as diagnostic milestones, and are influencing considerably medical decision making in term of patients’ management. The cost-effectiveness of genomic analysis as first-tier tests has been docume...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-07-01
|
Series: | New Genetics and Society |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/14636778.2019.1601008 |